Themes

Cancer and Blood Diseases

The Monash Partners Comprehensive Cancer Consortium (MPCCC) is the Cancer and Blood Diseases Theme. MPCCC is a strategic alliance of health service and research organisations working in partnership to improve outcomes for people affected by cancer. Our partners work collaboratively to bring a coordinated, multidisciplinary approach to innovating clinical oncology practices, improving cancer services and delivering the next generation of research for better cancer prevention, early detection and treatment of cancer.

Our goal is to improve patient experience and outcomes across the cancer care continuum, through world-class research and quality improvement.

This ambition will be realised by linking our expertise across basic translational, clinical, health service, population health and epidemiological research with the service delivery expertise of our clinical partners.

You can find out more about Monash Partners Comprehensive Cancer Consortium work here or follow MPCCC on Twitter and LinkedIn .

News and Resources

Cabrini Health formally commit to data sharing relationship with Monash Partners Cabrini Health has become the inaugural health service to formally commit to a data sharing relationship across the Monash Partners’… more
2021 Cystic Fibrosis research funding opportunity: Expression of Interest now open Monash Partners presents an opportunity to submit an Expression of Interest (EOI) for potential funding by 65km for Cystic Fibrosis.… more
Funding awarded to improve hospital communication, collaboration and reporting A new tool to improve hospital communication, collaboration and reporting is being developed thanks to recent project funding supported by… more
Message from Executive Director: Advancing best practice prevention of pressure injuries The NHMRC accredited Advanced Health Research Translation Centres (AHRTCs), which includes Monash Partners, are designed to facilitate strategic prioritised research… more

View all News & Resources